Related Experiment Video

Updated: Mar 18, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.0K

[Treatment strategy for high-risk localized prostate cancer]

Shintaro Narita, Takamitsu Inoue, Tomonori Habuchi

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |June 28, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    9.8K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.0K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.0K
    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    9.8K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.0K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.1K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K

    Articles linked to this work by shared authors, journal, and citation graph.

    Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

    International journal of urology : official journal of the Japanese Urological Association·2026

    Deferred Cytoreductive Nephrectomy With Partial Hepatectomy for Giant Renal Cell Carcinoma of the Right Kidney With Extensive Hepatic Invasion: A Case Report in the Era of Systemic Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.

    IJU case reports·2026

    IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft model.

    iScience·2026

    Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations.

    Cancer reports (Hoboken, N.J.)·2026

    Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

    Urologic oncology·2026

    Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

    Japanese journal of clinical oncology·2026

    AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

    American journal of rhinology & allergy·2026

    Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.

    The Journal of international medical research·2026

    HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.

    Science progress·2026

    Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.

    American journal of clinical oncology·2026

    Prognostic value of inflammation-immunity-nutrition score in cancer patients: a meta-analysis.

    Annals of medicine·2026

    ASSOCIATION OF SYNOVITIS ACTIVITY MEASURED BY SYNOVIAL TISSUE VOLUME (STV) AND DYNAMIC CONTRAST-ENHANCED (DCE)-MRI IN PATIENTS WITH INFLAMMATORY KNEE OSTEOARTHRITIS.

    Osteoarthritis imaging·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us